Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business (Details Narrative)

v3.22.2.2
Organization and Description of Business (Details Narrative) - $ / shares
6 Months Ended
Apr. 16, 2021
Jun. 30, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Reverse stock split   1-for-2
Supera Pharmaceuticals Inc [Member] | Asset Purchase Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Stock issued during period, shares, acquisitions 33,937,909  
MyMD Pharmaceuticals (Florida), Inc [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Common stock, par value $ 0.001  
Exchange ratio price per shares $ 0.7718  
Reverse stock split 1-for-2